Tissue Regenix Enters Agreement for OrthoPure XT

Tissue Regenix signed an exclusive distribution agreement with Joint Operations for the distribution of the OrthoPure XT product in the United Kingdom.

The initial agreement is for three years, subject to annual purchase minimums, and Joint Operations will add OrthoPure XT to its portfolio of products.

OrthoPure XT decellularized xenograft...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us